Samuel Manfrey
Urology · Bala Cynwyd, PANPI 1669477915
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,159 and has fallen 96.1% since, to $45 in 2023.
Across 157 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$631
- Johnson & Johnson$374
- Pfizer$234
- Acerus Pharmaceuticals Corporation$230
- Amgen$211
- Dendreon Pharmaceuticals LLC$155
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,76294%
- Education$1866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 30 | $631 |
| Johnson & Johnson(2 entities) | 26 | $374 |
| Pfizer | 18 | $234 |
| Acerus Pharmaceuticals Corporation | 11 | $230 |
| Amgen | 8 | $211 |
| Dendreon Pharmaceuticals LLC | 6 | $155 |
| Endo Pharmaceuticals Inc. | 10 | $137 |
| Axonics, Inc. | 1 | $102 |
| Bayer | 4 | $73 |
| Avadel Specialty Pharmaceuticals, LLC | 4 | $72 |
| AstraZeneca | 4 | $69 |
| Tolmar Pharmaceuticals, Inc. | 3 | $67 |
| AbbVie(2 entities) | 3 | $65 |
| Sun Pharmaceutical Industries Inc. | 2 | $52 |
| Coloplast | 3 | $48 |
| Metuchen Pharmaceuticals | 3 | $44 |
| Myovant Sciences Inc. | 2 | $42 |
| Aytu Biopharma, Inc. | 3 | $40 |
| Antares Pharma, Inc. | 2 | $37 |
| 180 Medical, Inc. | 2 | $37 |
| Teleflex LLC | 1 | $32 |
| Progenics Pharmaceuticals, Inc. | 1 | $31 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
| Boston Scientific | 2 | $30 |
| Blue Earth Diagnostics | 1 | $24 |
| Urogen Pharma, Inc. | 1 | $22 |
| Clovis Oncology, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Dentsply IH AB | 1 | $14 |
| West Therapeutics Development, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$102
How this compares
$2,948 in reported general payments places this provider in the 55th percentile of 596 urology providers in Pennsylvania.
Other urology in Bala Cynwyd
- Laurence BelkoffBala Cynwyd$47K
- John AndersonBethlehem$2.1M
- Demetrius BagleyPhiladelphia$739K
- Paul SieberLancaster$631K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
- Angelo BaccalaAllentown$166K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.